PDPN and breast carcinoma: Based on these results, the present study was undertaken to assess on the molecular level if and how podoplanin expressed by fibroblasts can affect malignancy-associated properties of breast cancer cells and to understand the role of podoplanin expressed by fibroblasts/CAFs in breast cancer progression.